A new therapeutic ap-proach for treating of bisphosphonate associ-ated osteonecrosis of the jaws (BP-ONJ)
The administration of bisphosphonates is always necessary if a disease with high levels of bone resorption is given. Osteone-crosis of the jaws can arise as a contraindi-cation. This clinical picture is explained by a reduced bone turnover caused by bisphos-phonates. To date it has not been possible to develop specific therapies. The accom-plished symptomatic treatment is currently limited to antibiotic administration, mouth-washes and in the worst case operational removal of the necrotic tissue.
It was now possible to demonstrate that the administration of an agent, which is already available, can raise the viability of os-teoblasts significantly. So the agent enables to work against the osteonecrosis in an early state.
Further Information: PDF
IMG Innovations-Management GmbH
Phone: +49 (0)631/31668-50
Contact
Dr. Klaus Kobek
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Trotting robots reveal emergence of animal gait transitions
A four-legged robot trained with machine learning by EPFL researchers has learned to avoid falls by spontaneously switching between walking, trotting, and pronking – a milestone for roboticists as well…
Innovation promises to prevent power pole-top fires
Engineers in Australia have found a new way to make power-pole insulators resistant to fire and electrical sparking, promising to prevent dangerous pole-top fires and reduce blackouts. Pole-top fires pose…
Possible alternative to antibiotics produced by bacteria
Antibacterial substance from staphylococci discovered with new mechanism of action against natural competitors. Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers…